Fundraising FoxMatrix Capital Management — Full Portfolio
11 tracked investments · listed companies and verified rows first
Maze Therapeutics develops precision medicines for common diseases with high unmet need, using its Compass platform based on human genetics and variant functionalization.
AI & Machine LearningBiotechSouth San Francisco, US
Charles Homcy(Director)Jason Coloma(Chief Executive Officer)in
Co-investorsAndreessen HorowitzARCH Venture PartnersForesite CapitalFrazier Life SciencesGV (Google Ventures)Hercules Capital, Inc.+9 more
Palleon Pharma develops small molecule and biologic drugs targeting autoimmune and inflammatory diseases using proprietary glycoscience platforms.
BiotechDigital HealthMedical DevicesWaltham, US
Jim Broderick(Co-Founder)inJohn Hennessy(Executive Officer)Karen Hong(Director)James Lee(Director)Stephen Hoffman(Director)Li Peng(Chief Scientific Officer)
Co-investorsPfizer VenturesPfizer Venture InvestmentsSR One Capital ManagementBioHealth Innovation, Inc.Takeda VenturesVertex Ventures HC
Solve Therapeutics is a clinical-stage oncology biotech developing antibody-drug conjugates (ADCs) and radiopharmaceuticals for solid tumors, built around its CloakLink hydrophilic cleavable linker platform and an integrated diagnostic for patient selection.
BiotechDeep TechHealthtechBelmont, US
David Johnson(Chief Executive Officer)Clayton Knox(President)Katti Jessen(SVP, Translational Sciences)inYakov Kogan(Head of Operations)Brian Lannutti(Research & Development Leadership)inLangdon Miller(Clinical Development Leadership)
Co-investorsDecheng CapitalYosemiteB Capital GroupB4 Capital
.jpeg){kind=logo}
Anumana is an AI-driven health technology company developing software-as-a-medical-device (SaMD) solutions that apply AI to standard 12-lead ECG data to detect early signs of cardiovascular disease and support clinical decision-making.
AI & Machine LearningBiotechDigital HealthMedical DevicesCambridge, US
Murali Aravamudan(Executive Chairman of the Board; co-founder of nference)inMaulik Nanavaty(Chief Executive Officer)inHarris Fishman(Executive Officer)Alan Colowick(Director)Cheranjit Rihal(Director)David Goel(Director)
Co-investorsNTT Venture CapitalMatrix
Bardavon Health Innovations provides clinical case management and care coordination services for injured workers in the workers' compensation space, guiding them through recovery and return-to-work processes.
Digital HealthEnterprise SoftwareHealthtechInsurTechOverland Park, US
Matthew Condon(CEO (until early 2024))inJeff Hogland(Executive Officer, Director)Paul Morris(Executive Officer, Director)in
BoardRobert K Green(Director)Matthew Ferguson(Director)
Co-investorsCobalt VenturesKCRise FundNewRoad Capital Partners, LLC
Blockdaemon provides blockchain infrastructure services including staking, node deployment, APIs, and wallet management across 60+ protocols for financial institutions and developers.
Crypto & Web3Data & InfrastructureEnergyEnterprise SoftwareFintechLos Angeles, US
Konstantin Richter(Founder)in
BoardEd Sim(Director)inGil Beyda(Director)in
Co-investors10SQ Capital (TenSquared)Amplify.LAAurum Venture PartnersBaroda VenturesBlockchain Coinvestorsboldstart ventures+33 more
Santa Clara-based provider of advanced threat protection software for detecting next-generation malware.
Santa Clara, US
Manoj Leelanivas(Executive Officer, Director)
Co-investorsClear VenturesDell Technologies CapitalSapphire VenturesZouk CapitalFoundation CapitalMatrix+1 more
Encoded develops gene therapies for neurological disorders through an integrated platform approach.
BiotechSouth San Francisco, US
Stephanie Tagliatela(Founder)inKartik Ramamoorthi, Ph.D.(Co-founder, Chief Executive Officer & Board Member)Kartik Ramamoorthi(Founder)
Co-investorsARCH Venture PartnersBioBritGV (Google Ventures)Illumina VenturesMenlo VenturesSoftBank Vision Fund+2 more
Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.
AI & Machine LearningBiotechDeep TechHealthtechCambridge, US
Travis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)inSimon Xi(Co-founder and CEO)inJackie Walling(CMO)Debasish Roychowdhury(Director)
Co-investorsDelos CapitalVivo CapitalAMR Action FundBoehringer Ingelheim Venture FundKorea Investment PartnersLilly Asia Ventures+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
EpiBiomePredible Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.